Genocea Biosciences Company

Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Industry: Atrificial Vectors and Immune Cells
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2006-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 13
Total Funding: 470569774
Estimated Revenue: $10M to $50M
Last Funding Date: 2020-07-22
Last Funding Type: Post-IPO Equity

Visit Website
website.inquiry@genocea.com
http://twitter.com/immunomix
Register and Claim Ownership